Broc A Flores

Title: Broc A Flores: Innovator in Pharmaceutical Chemistry

Introduction

Broc A Flores is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work primarily focuses on developing innovative compounds that have the potential to address various neurological and psychiatric disorders.

Latest Patents

One of his latest patents is for radiolabeled PDE10 inhibitors. This invention is directed to radiolabeled pyrimidinone compounds of general structural formula I, which are useful as radiotracers for quantitative imaging of PDE10 in mammals. Another significant patent involves 2,5-disubstituted morpholine orexin receptor antagonists. This invention pertains to 2,5-disubstituted morpholine amide compounds that act as antagonists of orexin receptors. These compounds are useful in the treatment or prevention of neurological and psychiatric disorders where orexin receptors play a crucial role. The invention also includes pharmaceutical compositions comprising these compounds and their applications in treating such diseases.

Career Highlights

Broc A Flores is currently associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Broc has collaborated with esteemed colleagues, including Christopher D Cox and John D Schreier. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Broc A Flores stands out as an influential inventor in the realm of pharmaceutical chemistry. His innovative patents and contributions to Merck Sharp & Dohme Corporation highlight his commitment to advancing medical science and improving patient outcomes.